AIG
FTH

American International Group’s Faeth Therapeutics FTH Stock Holding History

American International Group’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-519
Closed -$24K – 3248
2022
Q1 		$24K Sell
519
-36
-6% -$2.87K ﹤0.01% 3003
2021
Q4 		$64K Sell
555
-17
-3% -$2.54K ﹤0.01% 2881
2021
Q3 		$120K Buy
572
+359
+169% +$65.4K ﹤0.01% 2720
2021
Q2 		$42 Sell
213
-9
-4% -$2.22K ﹤0.01% 3022
2021
Q1 		$65 Buy
+222
New +$74.3K ﹤0.01% 2908

Other funds holding FTH

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

American International Group's FTH Position: Q2 2022 in Review

American International Group sold out of Faeth Therapeutics (FTH) in Q2 2022, closing a stake of 519 shares — an estimated $24K sold.

American International Group first reported a position in FTH in Q1 2021 and held it in 5 quarters. The position peaked at $120K in Q3 2021. 39 funds tracked by Wall St. Rank hold FTH as of Q2 2022.

  • American International Group reported no remaining Faeth Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 519 Faeth Therapeutics shares in Q2 2022, an estimated $24K.
  • American International Group first reported a position in Faeth Therapeutics in Q1 2021 and held it in 5 quarters.
  • American International Group's Faeth Therapeutics position peaked at $120K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.